Terrie Curran Email

CEO and President . Phathom Pharmaceuticals

Current Roles

Employees:
450
Revenue:
$14.9M
About
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders. We have created a nimble, entrepreneurial environment that fosters the spirit of collective ownership, accountability, proprietorship and achievement ᅢᄁ¬ツᆲ¬タン elements that are key to our success.
Phathom Pharmaceuticals Address
100 Campus Drive
Florham Park, null

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.